Human Growth Hormone (hGH)

DRUG2 trials

Sponsors

Enhanced Emirates Limited, Zhongshan Sansure Hygene Biomedicine Co., Ltd.

Conditions

Idiopathic Short Stature (ISS)Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes

Phase 3

Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short Stature

Not yet recruitingNCT07815626

Zhongshan Sansure Hygene Biomedicine Co., Ltd.Idiopathic Short Stature (ISS)

Start: 2026-09-01End: 2029-02-01Target: 240Updated: 2026-09-11

Unknown Phase

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling by invitationNCT07568574

Enhanced Emirates LimitedSafety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes

Start: 2026-03-12End: 2033-03-01Target: 60Updated: 2026-05-06